MiMedx Group Inc. ( (MDXG) ) has released its Q1 earnings. Here is a breakdown of the information MiMedx Group Inc. presented to its investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MiMedx Group Inc. is a leading healthcare company specializing in wound care, burn, and surgical products, known for its innovative healing solutions. In the first quarter of 2025, MiMedx reported net sales of $88 million, marking a 4% increase from the previous year, with a net income of $7 million and an adjusted EBITDA of $17 million. The company’s surgical products experienced significant growth, while wound products saw a slight decline. Operating expenses rose due to increased sales commissions and legal costs, impacting net income compared to the previous year. Looking ahead, MiMedx reaffirms its expectation for high single-digit net sales growth in 2025, with a focus on expanding its product portfolio and maintaining an adjusted EBITDA margin above 20%.